Georgios F Samelis
Affiliation: University of Athens
- Survival benefit with the combination of docetaxel, gemcitabine and erlotinib in advanced and/or metastatic pancreatic cancer patientsGeorgios F Samelis
Oncology Department, University of Athens, Medical School, Greece
Hepatogastroenterology 58:1776-81. 2011..The aim of the present study was to record the efficacy and safety of gemcitabine-erlotinib plus docetaxel combination therapy in patients with advanced and/or metastatic pancreatic cancer...